CD28 regulates the translation of Bcl-xL via the phosphatidylinositol 3-kinase/mammalian target of rapamycin pathway

Journal of Immunology

Volumn 174, Issue 1, 2005, Pages 180-194

  Wu, Linda X ^a,b   La Rose, Jose ^b   Chen, Liane ^a,b   Neale, Chris ^b   Mak, Tak ^a,b   Okkenhaug, Klaus ^c   Wange, Ronald ^d   Rottapel, Robert ^a,b,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c BABRAHAM INSTITUTE   (United Kingdom)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BINDING PROTEIN; CD28 ANTIGEN; INTERLEUKIN 2; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN BCL 2; PROTEIN BCL XL; RAPAMYCIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL DEATH; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION REGULATION; IMMUNE RESPONSE; IMMUNOSTIMULATION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYSOME; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TRANSLATION INITIATION;

EID: 10844280747     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.174.1.180     Document Type: Article

References (60)

1. Lafferty, K. J., and A. J. Cunningham. 1975. A new analysis of allogeneic interactions. Aust. J. Exp. Biol Med. Sci. 53:27.
2. Jenkins, M. K., P. S. Taylor, S. D. Norton, and K. B. Urdahl. 1991. CD28 delivers a costimulatory signal involved in antigen-specific IL-2 production by human T cells. J. Immunol. 147:2461.
3. Ward, S. G. 1996. CD28: a signalling perspective. Biochem. J. 318:361.
4. Alegre, M. L., K. A. Frauwirth, and C. B. Thompson. 2001. T-cell regulation by CD28 and CTLA-4. Nat. Rev. Immunol. 1:220.
5. Noel, P. J., L. H. Boise, J. M. Green, and C. B. Thompson. 1996. CD28 co-stimulation prevents cell death during primary T cell activation. J. Immunol. 157:636.
6. Sperling, A. I., J. A. Auger, B. D. Ehst, I. C. Rulifson, C. B. Thompson, and J. A. Bluestone. 1996. CD28/B7 interactions deliver a unique signal to naive T cells that regulates cell survival but not early proliferation. J. Immunol. 157:3909.
7. Boise, L. H., A. J. Minn, P. J. Noel, C. H. June, M. A. Accavitti, T. Lindsten, and C. B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-xL. Immunity 3:87.
8. Cantley, L. C. 2002. The phosphoinositide 3-kinase pathway. Science 296:1655.
9. Pages, F., M. Ragueneau, R. Rottapel, A. Truneh, J. Nunes, J. Imbert, and D. Olive. 1994. Binding of phosphatidylinositol-3-OH kinase to CD28 is required for T-cell signalling. Nature 369:327.
10. Prasad, K. V., Y. C. Cai, M. Raab, B. Duckworth, L. Cantley, S. E. Shoelson, and C. E. Rudd. 1994. T-cell antigen CD28 interacts with the lipid kinase phosphatidylinositol 3-kinase by a cytoplasmic Tyr(P)-Met-xaa-Met motif. Proc. Natl. Acad. Sci. USA 91:2834.
11. Truitt, K. E., C. M. Hicks, and J. B. Imboden. 1994. Stimulation of CD28 triggers an association between CD28 and phosphatidylinositol 3-kinase in Jurkat T cells. J. Exp. Med. 179:1071.
12. Oktenhaug, K., L. Wu, K. M. Garza, J. La Rose, W. Khoo, B. Odermatt, T. W. Mak, P. S. Ohashi, and R. Rottapel. 2001. A point mutation in CD28 distinguishes proliferative signals from survival signals. Nat. Immunol. 2:325.
13. Scheid, M. P., and J. R. Woodgett. 2001. PKB/AKT: functional insights from genetic models. Nat. Rev. Mol. Cell. Biol. 2:760.
14. Chan, T. O., S. E. Rittenhouse, and P. N. Tsichlis. 1999. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 68:965.
15. Vanhaesebroeck, B., and D. R. Alessi. 2000. The PI3K-PDK1 connection: more than just a road to PKB. Biochem. J. 346:561.
16. Raught, B., and A. C. Gingras. 1999. eIF4E activity is regulated at multiple levels. Int. J. Biochem. Cell. Biol. 31:43.
17. Inoki, K., Y. Li, T. Zhu, J. Wu, and K. L. Guan. 2002. TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat. Cell. Biol. 4:648.
18. Gao, X., Y. Zhang, P. Arrazola, O. Hino, T. Kobayashi, R. S. Yeung, B. Ru, and D. Pan. 2002. Tsc tumour suppressor proteins antagonize amino-acid-TOR signalling. Nat. Cell. Biol. 4:699.
19. Tee, A. R., D. C. Fingar, B. D. Manning, D. J. Kwiatkowski, L. C. Cantley, and J. Blenis. 2002. Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling. Proc. Natl. Acad. Sci. USA 99:13571.
20. Avruch, J., C. Belham, Q. Weng, K. Hara, and K. Yonezawa. 2001. The p70 S6 kinase integrates nutrient and growth signals to control translational capacity. Prog. Mol. Subcell. Biol. 26:115.
21. Gingras, A. C., B. Raught, and N. Sonenberg. 2001. Regulation of translation initiation by FRAP/mTOR. Genes Dev. 15:807.
22. Gingras, A. C., S. G. Kennedy, M. A. O'Leary, N. Sonenberg, and N. Hay. 1998. 4E-BP1, a repressor of mRNA translation, is phosphorylated and inactivated by the Akt(PKB) signaling pathway. Genes Dev. 12:502.
23. Gingras, A. C., B. Raught, and N. Sonenberg. 1999. eIF4 initiation factors: effectors of mRNA recruitment to ribosomes and regulators of translation. Annu. Rev. Biochem. 68:913.
24. Beretta, L., A. C. Gingras, Y. V. Svitkin, M. N. Hall, and N. Sonenberg. 1996. Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. EMBO J. 15:658.
25. Takata, M., W. Ogawa, T. Kitamura, Y. Hino, S. Kuroda, K. Kotani, A. Klip, A. C. Gingras, N. Sonenberg, and M. Kasuga. 1999. Requirement for Akt (protein kinase B) in insulin-induced activation of glycogen synthase and phosphorylation of 4E-BP1 (PHAS-1). J. Biol. Chem. 274:20611.
26. Dufner, A., M. Andjelkovic, B. M. Burgering, B. A. Hemmings, and G. Thomas. 1999. Protein kinase B localization and activation differentially affect S6 kinase 1 activity and eukaryotic translation initiation factor 4E-binding protein 1 phosphorylation. Mol. Cell. Biol. 19:4525.
27. Clemens, M. J., and U. A. Bommer. 1999. Translational control: the cancer connection. Int. Biochem. Cell. Biol. 31:1.
28. Miyamoto, S., S. R. Kimball, and B. Safer. 2000. Signal transduction pathways that contribute to increased protein synthesis during T-cell activation. Biochim. Biophys. Acta 1494:28.
29. L levels in vivo. J. Exp. Med. 191:1721.
30. Bell, M. P., C. J. Huntoon, D. Graham, and D. J. McKean. 2001. The analysis of costimulatory receptor signaling cascades in normal T lymphocytes using in vitro gene transfer and reporter gene analysis. Nat. Med. 7:1155.
31. Mikulits, W., B. Pradet-Balade, B. Habermann, H. Beug, J. A. Garcia-Sanz, and E. W. Mullner. 2000. Isolation of translationally controlled mRNAs by differential screening. FASEB J. 14:1641.
32. Radvanyi, L. G., Y. Shi, H. Vaziri, A. Sharma, R. Dhala, G. B. Mills, and R. G. Miller. 1996. CD28 costimulation inhibits TCR-induced apoptosis during a primary T cell response. J. Immunol. 156:1788.
33. Augustine, J. A., S. L. Sutor, and R. T. Abraham. 1991. Interleukin 2- and polyomavirus middle T antigen-induced modification of phosphatidylinositol 3-kinase activity in activated T lymphocytes. Mol. Cell. biol. 11:4431.
34. Merida, I., E. Diez, and G. N. Gaulton. 1991. IL-2 binding activates a tyrosine-phosphorylated phosphatidylinositol-3-kinase. J. Immunol. 147:2202.
35. Gonzalez-Garcia, A., I. Merida, A. C. Martinez, and A. C. Carrera. 1997. Intermediate affinity interleukin-2 receptor mediates survival via a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 272:10220.
36. Brunn, G. J., C. C. Hudson, A. Sekulic, J. M. Williams, H. Hosoi, P. I. Houghton, J. C. Lawrence, Jr., and R. T. Abraham. 1997. Phosphorylation of the translational represser PHAS-I by the mammalian target of rapamycin. Science 277:99.
37. Jones, R. G., A. R. Elford, M. J. Parsons, L. Wu, C. M. Krawczyk, W. C. Yeh, R. Hakem, R. Rottapel, J. R. Woodgett, and P. S. Ohashi. 2002. CD28-dependent activation of protein kinase B/Akt blocks Fas-mediated apoptosis by preventing death-inducing signaling complex assembly. J. Exp. Med. 196:335.
38. Shan, X., M. J. Czar, S. C. Bunnell, P. Liu, Y. Liu, P. L. Schwartzberg, and R. L. Wange. 2000. Deficiency of PTEN in Jurkat T cells causes constitutive localization of Itk to the plasma membrane and hyperresponsiveness to CD3 stimulation. Mol. Cell. Biol. 20:6945.
39. Garcia-Sanz, J. A., W. Mikulits, A. Livingstone, I. Lefkovits, and E. W. Mullner. 1998. Translational control: a general mechanism for gene regulation during T cell activation. FASEB J. 12:299.
40. Smith, C. W., J. G. Klaasmeyer, J. B. Edeal, T. L. Woods, and S. S. Jones. 1999. Effects of serum deprivation, insulin and dexamethasone on polysorae percentages in C2C12 myoblasts and differentiating myoblasts. Tissue Cell 31:451.
41. 2-terminal kinase pathway. Science 280:1945.
42. Harhaj, E. W., and S. C. Sun. 1998. IκB kinases serve as a target of CD28 signaling. J. Biol. Chem. 273:25185.
43. Kane, L. P., J. Lin, and A. Weiss. 2002. It's all Rel-ative: NF-κB and CD28 costimulation of T-cell activation. Trends Immunol. 23:413.
44. Diehn, M, A. A. Alizadeh, O. J. Rando, C. L. Liu, K. Stankunas, D. Botstein, G. R. Crabtree, and P. O. Brown. Genomic expression programs and the integration of the CD28 costimulatory signal in T cell activation. Proc. Natl. Acad. Sci. USA 02:11796.
45. Chen, L., M. Woo, R. Hakem, and R. G. Miller. 2003. Perforin-dependent activation-induced cell death acts through caspase 3 but not through caspases 8 or 9. Eur. J. Immunol. 33:769.
46. Spaner, D., K. Raju, L. Radvanyi, Y. Lin, and R. G. Miller. 1998. A role for perform in activation-induced cell death. J. Immunol. 160:2655.
47. Kirchhoff, S., W. W. Muller, M. Li-Weber, and P. H. Krammer. 2000. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells. Eur. J. Immunol. 30:2765.
48. Fang, L. W., T. S. Tai, W. N. Yu, F. Liao, and M. Z. Lai. 2004. Phosphatidylinositide 3-kinase priming couples c-FLIP to T cell activation. J. Biol. Chem. 279:13.
49. Panka, D. J., T. Mono, T. Suhara, K. Walsh, and J. W. Mier. 2001. Phosphatidylinositol 3-kinase/Akt activity regulates c-FLIP expression in tumor cells. J. Biol. Chem. 276:6893.
50. Okkenhaug, K., A. Bilancio, G. Farjot, H. Priddle, S. Sancho, E. Peskett, W. Pearce, S. E. Meek, A. Salpekar, M. D. Waterfield, et al. 2002. Impaired B and T cell antigen receptor signaling in p110δ PI 3-kinase mutant mice. Science 297:1031.
51. Schmelzle, T., and M. N. Hall. 2000. TOR, a central controller of cell growth. Cell 103:253.
52. Fingar D. C., and J. Blenis. Target of rapamycin (TOR): an integrator of nutrient and growth factor signals and coordinator of cell growth and cell cycle progression. Oncogene 23:3151.
53. Dennis, P. B., A. Jaeschke, M. Saitoh, B. Fowler, S. C. Kozma, and G. Thomas. 2001. Mammalian TOR: a homeostatic ATP sensor. Science 294:1102.
54. Fang, Y., M. Vilella-Bach, R. Bachmann, A. Flanigan, and J. Chen. 2001. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science 294:1942.
55. Hidalgo, M., and E. K. Rowinsky. 2000. The rapamycin-sensitive signal transduction pathway as a target for cancer therapy. Oncogene 19:6680.
56. Frauwirth, K. A., J. L. Riley, M. H. Harris, R. V. Parry, J. C. Rathmell, D. R. Plas, R. L. Elstrom, C. H. June, and C. B. Thompson. 2002. The CD28 signaling pathway regulates glucose metabolism. Immunity 16:769.
57. Kleijn, M., and C. G. Proud. 2002. The regulation of protein synthesis and translation factors by CD3 and CD28 in human primary T lymphocytes. BMC Biochem. 3:11.
58. Ghosh, P., M. A. Buchholz, S. Yano, D. Taub, and D. L. Longo. 2002. Effect of rapamycin on the cyclosporin A-resistant CD28-mediated costimulatory pathway. Blood 99:4517.
59. Kane, L. P., P. G. Andres, K. C. Howland, A. K. Abbas, and A. Weiss. 2001. Akt provides the CD28 costimulatory signal for up-regulation of IL-2 and IFN-γ but not TH2 cytokines. Nat. Immunol. 2:37.
60. Eder, A. M., L. Dominguez, T. F. Franke, and J. D. Ashwell. 1998. Phosphoinositide 3-kinase regulation of T cell receptor-mediated interleukin-2 gene expression in normal T cells. J. Biol. Chem. 273:28025.